
Pfizer Says Acquiring Medivation For $14 Billion
Umer Jamshaid Published August 22, 2016 | 10:11 PM

NEW YORK, (APP - UrduPoint / Pakistan Point News - 20th August, 2016) - Pfizer will purchase biotech firm Medivation, which specializes in cancer treatments, for some $14 billion, the US pharma giant said in a statement on Monday. Pfizer's offer for the San Francisco-based Medivation goes far beyond the company's market value of $11.1 billion. The boards of directors of both companies have unanimously approved the merger, the statement said. "The proposed acquisition of Medivation is expected to immediately accelerate revenue growth and drive overall earnings growth potential for Pfizer," said Ian Read, Pfizer chairman and chief executive officer. The transaction is a snub to the French pharmaceutical group Sanofi, which earlier offered $58 a share, which Medivation rejected in last month. Medivation turned down an uninvited offer worth about $10 billion from Sanofi as "not in the best interests" of its shareholders. The company's founder said Pfizer, by contrast, was the ideal marriage partner.
"We believe the combination with Pfizer is the right next step in our growth trajectory and is a testament to the passion and dedication by which the Medivation team has delivered on our mission to profoundly transform patients' lives through medically innovative therapies," said David Hung, founder, president and CEO of Medivation.
"This compelling transaction will deliver significant and immediate value to our stockholders and provides new opportunities for our employees as part of a larger company." By purchasing Medivation, Pfizer would add to its portfolio the drug Xtandi, a promising treatment against prostate cancer that analysts estimate will generate some $1.33 billion in annual sales by 2020.
It also produces the promising new talazoparib breast cancer drug, currently in a phase three study. The purchase of Medivation, if approved by regulators, would be Pfizer's biggest buy since it bought the medical device company Hospira last year for $17 billion.
Related Topics
Recent Stories

Fujairah Crown Prince attends Prophet Mohammed’s birthday commemoration

Sultan bin Ahmed witnesses agreement to implement 'Sharjah Sat-2'

COP28 Presidency tells United Nations General Assembly: “Climate change is our ..

ZHO disseminates sign language for deaf members of society, facilitate their emp ..

Abu Dhabi City Municipality hosts event promoting Beauty of Al Shamkha gardens

Nawaz Sharif did not escape from jail to fly to London, says Solangi

A Mighty Price-drop Comes to a Stellar realme C-Series Line-up

Sharjah Airport receives Saudi passengers with festive atmosphere

World Cup 2023: Indian Visa delay forces Pakistan to cancel 'team-bounding trip' ..

4th annual Emirates Oncology Society conference launched in Dubai

President Xi to inaugurate Asian Games today

President stresses for innovative steps to enroll 27mln children in schools
More Stories From World
-
Russian soldier missing after attack on Crimea naval HQ: Moscow
21 hours ago -
Karabakh rebels say negotiating their troops' withdrawal
22 hours ago -
Charles in Bordeaux on last day of climate-focused France trip
22 hours ago -
Debris and dead bodies clutter flood-hit Libyan port
22 hours ago -
Over 10,000 power pilferers netted across the MEPCO region so far
23 hours ago -
Africa sentences exiled ex-leader Bozize to life
24 hours ago
-
Russia says Crimea naval HQ hit in missile attack
24 hours ago -
Climate crisis has 'opened the gates to hell' UN chief tells summit
3 days ago -
Pakistan's traditional products attract China-ASEAN Expo visitors
3 days ago -
Son of ousted Gabon leader held in corruption case
3 days ago -
India's lower house votes to reserve third of seats for women: speaker
3 days ago -
Azerbaijan says aims for 'peaceful reintegration' of Karabakh Armenians
3 days ago